Open access · CC-BY
via OpenAlex
Lead Exposure, Aging and Biomarkers in Alzheimer's Disease
· 2010
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease. To investigate AD risk factors, we reviewed epidemiologic case control studies and recent research for AD's connection to the environment. Next, we examined the number one risk factor in AD, aging. We compared and contrasted lifespan profiles of AD-associated mRNA and protein levels in monkeys and mice. The AD-related biomarkers were APP mRNA and protein; Aβ levels; specificity protein 1 (SP1); and the β-amyloid precursor cleaving enzyme (BACE1). In mice, APP and Sp1 mRNA and their protein products were elevated late in life; Aβ levels declined. In monkeys, APP, Sp1, and BACE1 mRNA declined in old age, while their protein products and Aβ levels rose. Proteolytic processing in both species did not match the production of Aβ. We further examined another specific risk factor that can alter AD related biomarkers: developmental lead (Pb) exposure. Our hypothesis was that Pb alters the lifespan profiles of AD-associated mRNA and protein levels in the rodent cortex but not in the cerebellum. APP mRNA and protein were initially elevated following developmental exposure, returned to basal levels in adulthood and remerged high late in life; Aβ1-42 levels were also increased. In the cerebellum there was no difference in the gene expression of APP between non-exposed and Pb-exposed animals. These data show that developmental Pb exposure has an effect on AD-related genes in regions associated with AD-pathology demonstrating that environmental conditions early in life can enhance neurodegeneration. Microarray analysis was conducted to take a genome wide view of what occurs with developmental Pb exposure. Gene expression of young and old animals was analyzed and genes that were down- and up-regulated (≥ 2 fold) were identified; 150 were significant. The major findings of this study found an up-regulation of genes related to the immune response, metal binding, metabolism and transcription/transduction coupling. In Pb-reprogrammed aging, there was a repression in these genes suggesting that disturbances in developmental stages of the brain had compromised the ability to defend against age-related stressors and thus may promote the neurodegenerative processes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.23860/diss-2398
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Dosunmu, A. (2010). Lead Exposure, Aging and Biomarkers in Alzheimer's Disease. https://doi.org/10.23860/diss-2398
Vancouver
Dosunmu A. Lead Exposure, Aging and Biomarkers in Alzheimer's Disease. 2010. doi:10.23860/diss-2398.
BibTeX
@article{aderemi2010LeadEx,
title = {Lead Exposure, Aging and Biomarkers in Alzheimer's Disease},
author = {Aderemi Dosunmu},
year = {2010},
doi = {10.23860/diss-2398},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neurobiology of Aging 2021
Preprint · OA
Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age
2026
Preprint
Clinically Relevant Biomarkers of Alzheimer's Disease Are Associated with Age and Cortical Atrophy in Chimpanzees ( <i>Pan troglodytes</i> )
medRxiv 2020
Preprint · CC-BY
A meta-analysis of brain DNA methylation across sex, age and Alzheimer’s disease points for accelerated epigenetic aging in neurodegeneration
British Journal of Sports Medicine 2014
Citation only
22 Transcriptomic Signatures Of Tendon Ageing
2022
Open access · CC0
Investigating the temporal pattern of neuroimaging-based brain age estimation as a biomarker for Alzheimer's disease related neurodegeneration
Frontiers in Aging Neuroscience 2021
Open access · CC-BY